Scholay

学术搜索 · AI 审稿 · LaTeX 协作

David H. Boldt

机构:University of California, Los Angeles

发表论文 87 篇 · 总被引 3652 次 · h-index 35

代表论文

  • Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group (1988 · American Journal of Hematology · 被引 406)
  • A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. (1989 · Journal of Clinical Oncology · 被引 236)
  • A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. (1992 · Journal of Clinical Oncology · 被引 160)
  • A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma. (1991 · Journal of Clinical Oncology · 被引 99)
  • New Perspectives on Iron: An Introduction (1999 · The American Journal of the Medical Sciences · 被引 95)
  • Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. (1993 · PubMed · 被引 90)